Open Access

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

Topic: Chronic Heart Failure
Organised by CHANGE IME supported by an unrestricted educational grant from AstraZeneca

Congress Presentation

About the speaker

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
16 presentations

2 more presentations in this session

Heart failure in context.

Speaker: Professor C. Linde (Stockholm, SE)


Treating the whole spectrum of heart failure.

Speaker: Professor G. Rosano (London, GB)


Access the full session

SGLT2 inhibitors and heart failure in the cardiorenal spectrum

Speakers: Doctor M. Vaduganathan, Professor C. Linde, Professor G. Rosano

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb